Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
QuintilesIMS
Queensland Health
McKesson
Novartis
Medtronic
Moodys
Healthtrust
Accenture

Generated: February 23, 2018

DrugPatentWatch Database Preview

MEFOXIN Drug Profile

« Back to Dashboard

When do Mefoxin patents expire, and when can generic versions of Mefoxin launch?

Mefoxin is a drug marketed by Mylan Institutional and Merck and is included in four NDAs.

The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Drug patent expirations by year for MEFOXIN
Medical Subject Heading (MeSH) Categories for MEFOXIN

US Patents and Regulatory Information for MEFOXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 062757-001 Jan 8, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-004 Sep 20, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 050517-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 063182-001 Jan 25, 1993 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 050517-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 062757-002 Jan 8, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-003 Sep 20, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional MEFOXIN cefoxitin sodium INJECTABLE;INJECTION 050517-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-002 Sep 20, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-001 Sep 20, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Cantor Fitzgerald
Express Scripts
Federal Trade Commission
Deloitte
McKinsey
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot